Eight Roads
Eight Roads Ventures is a global venture capital firm and the proprietary investment arm of Fidelity International Limited, with offices in China, India, Japan, and the UK. The firm focuses on early venture and growth stage investments, primarily in technology sectors such as software as a service, healthcare IT, financial technology, and telecommunications. It seeks to invest in emerging growth companies across Asia, Europe, and Israel, typically committing between $1.29 million and $30 million. Eight Roads Ventures aims to take minority or majority stakes in its portfolio companies and prefers to hold board seats. The firm has various specialized funds, including those targeting healthcare and technology in China, further solidifying its commitment to fostering innovation in dynamic markets.
Spry is a cloud-based operating system that allows movement health professionals to collect and analyze patient data in real time.
Doceree is a healthcare marketing technology company. They specialize in providing a platform and solutions for pharmaceutical and healthcare brands to connect with healthcare professionals (HCPs). Doceree's platform may include features like targeted advertising, data analytics, and tools to help pharmaceutical companies and healthcare brands effectively reach and engage with healthcare professionals in a compliant and efficient manner.
b-ONE Ortho Corp. develops orthopedic healthcare solutions. The company’s product includes B-One total hip system which features coating technology and instrumentation. The system includes the Juveno bone-conserving femoral prosthesis and the B-One primary acetabular systems. b-ONE Ortho Corp. was founded in 2015 and is based in Cedar Knolls, New Jersey. The company has additional offices in Shanghai and Suzhou, China.
b-ONE Ortho Corp. develops orthopedic healthcare solutions. The company’s product includes B-One total hip system which features coating technology and instrumentation. The system includes the Juveno bone-conserving femoral prosthesis and the B-One primary acetabular systems. b-ONE Ortho Corp. was founded in 2015 and is based in Cedar Knolls, New Jersey. The company has additional offices in Shanghai and Suzhou, China.
b-ONE Ortho Corp. develops orthopedic healthcare solutions. The company’s product includes B-One total hip system which features coating technology and instrumentation. The system includes the Juveno bone-conserving femoral prosthesis and the B-One primary acetabular systems. b-ONE Ortho Corp. was founded in 2015 and is based in Cedar Knolls, New Jersey. The company has additional offices in Shanghai and Suzhou, China.
Symbiomix Therapeutics, LLC is a biopharmaceutical company focused on developing innovative treatments for serious women's health infections, particularly bacterial vaginosis (BV). Founded in 2012, the company is based in Newark, New Jersey, with additional offices in Baltimore, Maryland, and Hamden, Connecticut. Its lead product, Solosec (secnidazole), is a novel 5-nitroimidazole antibiotic designed for a one-time oral treatment of bacterial vaginosis, addressing a significant unmet need in women's healthcare. Symbiomix operates as a subsidiary of Lupin Inc. and is supported by prominent healthcare venture capital firms. The company aims to provide effective therapeutic options for gynecologic infections that have been historically overlooked.
Transave
Venture Round in 2006
Transave, Inc., a biotechnology company, develops inhaled pharmaceuticals for the treatment of lung diseases. The company’s liposomal technology allows the release of drug in the lung's microenvironment. Its products also include Arikace for the treatment of gram-negative lung infections and pseudomonas infections in cystic fibrosis patients; and cisplatin lipid complex for the treatment of cancers affecting the lungs. Transave, Inc. was founded in 1997 and is headquartered in Monmouth Junction, New Jersey. As of December 1, 2010, Transave, Inc. operates as a subsidiary of Insmed Incorporated.
QUMAS specializes in enterprise compliance management software, offering an integrated platform that standardizes and streamlines compliance tasks for organizations across various industries. The company focuses on delivering a closed-loop compliance model that allows enterprises to consolidate their compliance programs, significantly reducing costs and enhancing competitive advantage. With a strong track record in highly regulated sectors such as financial services and life sciences, QUMAS is well-equipped to support centralized compliance efforts for any organization. Its solutions help ensure adherence to a comprehensive range of global regulations, making it a valuable partner for businesses navigating complex compliance landscapes.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.